MB, Levis & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.96K Hold
25
﹤0.01% 200
2025
Q4
$3.15K Hold
25
﹤0.01% 202
2025
Q3
$3.66K Hold
25
﹤0.01% 195
2025
Q2
$3.9K Hold
25
﹤0.01% 226
2025
Q1
$4.12K Hold
25
﹤0.01% 224
2024
Q4
$4.07K Hold
25
﹤0.01% 228
2024
Q3
$4.88K Buy
+25
New +$4.61K ﹤0.01% 223

Other funds holding ZTS

MB, Levis & Associates's ZTS Position: Q1 2026 in Review

MB, Levis & Associates held its Zoetis (ZTS) position steady in Q1 2026 at 25 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #200.

MB, Levis & Associates first reported a position in ZTS in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.88K in Q3 2024. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • MB, Levis & Associates held 25 shares of Zoetis worth $2.96K as of Q1 2026.
  • MB, Levis & Associates left its Zoetis share count unchanged in Q1 2026.
  • Zoetis made up ﹤0.01% of MB, Levis & Associates's portfolio in Q1 2026, its #200 holding.
  • MB, Levis & Associates first reported a position in Zoetis in Q3 2024 and has held it in 7 quarters since.
  • MB, Levis & Associates's Zoetis position peaked at $4.88K in Q3 2024.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.